You are viewing: Asia Pacific Biopreservation Market analysis
Part of: Biopreservation Market (Global)

The Asia Pacific Biopreservation Market was valued at $986.5 Million in 2024 and projected to reach to $1661.4 Million by 2029, representing a compound annual growth rate of 11.0%. Asia Pacific's biopreservation market is poised for exceptional growth, driven by substantial investments in regenerative medicine, cell therapy infrastructure, and biobanking capabilities.

Asia Pacific Biopreservation Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Asia Pacific Biopreservation Market Trends and Insights

  • Asia Pacific's 11.0% compound annual growth rate outpaces the global average, driven by increasing investments in regenerative medicine, cell therapy infrastructure, and biobanking capabilities across the region.
  • Asia Pacific's growing pharmaceutical and biotechnology sectors, coupled with rising healthcare expenditure and government support for life sciences innovation, are accelerating adoption of advanced preservation technologies. Asia Pacific's biopreservation market is benefiting from expanding clinical applications in stem cell research, organ transplantation, and personalized medicine.
  • The region's emerging economies are establishing state-of-the-art cryopreservation facilities and biorepositories, while established markets like Japan, South Korea, and Australia lead in technology adoption.
  • Asia Pacific's demographic trends, aging population, and increasing prevalence of chronic diseases are creating sustained demand for biopreservation solutions through 2029..

Key Market Statistics

  • CAGR (2024-2029) 11.0% CAGR
  • Market Size, 2024 ~USD 986.5 Million
  • Forecast, 2029 ~USD 1661.4 Million
  • Geography Asia Pacific

Asia Pacific Biopreservation Market Overview

Regional Market Leadership :

Asia Pacific's biopreservation market commands USD 986.5 million in 2024, with an 11% CAGR significantly outpacing the global average of 9.8%, positioning the region as a high-growth hub for biopreservation technologies and services.

Cell Therapy & Regenerative Medicine Boom :

Rapid expansion of cell therapy infrastructure and regenerative medicine investments across Asia Pacific are driving demand for advanced biopreservation solutions, with China and Japan leading clinical trial adoption and commercialization efforts.

Biobanking Infrastructure Growth :

Strategic development of biobanking capabilities throughout Asia Pacific, particularly in India and Southeast Asia, is creating substantial opportunities for cryopreservation systems, storage solutions, and sample management technologies.

Forecast Growth Trajectory :

The market is projected to reach USD 1,661.4 million by 2029, representing a 68.4% increase over five years, driven by rising healthcare investments, regulatory framework improvements, and increasing adoption of precision medicine across the region.

Asia Pacific Biopreservation Market Dynamics

  • China, Japan, and India are emerging as innovation hubs, with governments and private sectors prioritizing stem cell research and personalized medicine initiatives.
  • The region's expanding pharmaceutical and biotechnology sectors are accelerating demand for reliable biopreservation technologies. Regulatory harmonization efforts and increasing collaboration between academic institutions and commercial entities are further catalyzing market expansion.
  • Rising healthcare expenditures, coupled with growing awareness of biopreservation's critical role in advancing therapeutic development, position Asia Pacific as the fastest-growing biopreservation market globally.
  • By 2029, the region will represent a significant portion of global biopreservation revenue, attracting major international players and fostering local innovation ecosystems..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • Asia Pacific biopreservation market will grow from USD 986.5M (2024) to USD 1,661.4M (2029) at 11.0% CAGR, outpacing global growth.
    • Asia Pacific's expanding cell therapy and regenerative medicine sectors are primary drivers of biopreservation technology adoption.
    • Asia Pacific's emerging economies are rapidly building biobanking and cryopreservation infrastructure to support life sciences research.
    • Asia Pacific's aging demographics and chronic disease burden create sustained long-term demand for biopreservation solutions through 2029.

    Biopreservation Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment BIOPRESERVATION EQUIPMENT (Product)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.8% from 2024 to 2029
    Largest Segment BIOPRESERVATION MEDIA (Product)
    Market Size Base Year (Billions) ~USD 4.45 (2024)
    Revenue Forecast (Billions) ~USD 7.1 (2029)
    Segments Covered Product, Type, Biospecimen, Application, End User, Transplant Type

    Asia Pacific Biopreservation Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Biopreservation Accessories
    • Biopreservation Equipment
    • Biopreservation Media

    By Type

    • Alarm Monitoring Systems
    • Centrifuges
    • Cryogenic Storage Systems
    • Cryopreservation Media
    • Freezers
    • Hypothermic Preservation Media
    • Incubators
    • Other Biopreservation Equipment
    • Other Equipment
    • Refrigerators
    • Temperature Control Systems
    • Thawing Equipment

    By Biospecimen

    • Human Tissue Samples
    • Organs
    • Other Biospecimens
    • Stem Cells

    By Application

    • Other Applications
    • Research Applications
    • Therapeutic Applications

    By End User

    • Biobanks
    • Gene Banks
    • Hospitals
    • Other End Users

    By Transplant Type

    • Cord Blood Transplants
    • Organ Transplants

    Target Audience

    • Biopreservation Technology Manufacturers : Evaluate Asia Pacific market demand for cryopreservation systems, storage solutions, and biopreservation reagents to optimize product development, pricing strategies, and regional distribution networks.
    • Cell Therapy & Regenerative Medicine Companies : Assess biopreservation service requirements and infrastructure gaps across Asia Pacific to identify partnership opportunities, outsourcing options, and market expansion potential for therapeutic development.
    • Biobanking & Research Institutions : Benchmark biopreservation capabilities against regional standards, identify technology upgrades, and understand market trends to enhance sample preservation quality and operational efficiency.
    • Healthcare Investors & Private Equity : Identify high-growth biopreservation companies, biobanking networks, and cell therapy infrastructure providers in Asia Pacific with strong investment potential and exit opportunities.
    • Government & Healthcare Policy Makers : Understand biopreservation market dynamics, infrastructure gaps, and investment needs to develop supportive policies, funding mechanisms, and regulatory frameworks for precision medicine advancement.

    Asia Pacific vs. other regions

    HowAsia Pacific compares to the other 3 regional blocs covered in this market.

    North America
    ~USD 2852.9 Million · 10.1% wtd CAGR ·
    Europe
    ~USD 1604.4 Million · 9.1% wtd CAGR ·
    Latin America
    ~USD 418.5 Million · 8.7% wtd CAGR ·
    Middle East & Africa
    ~USD 334 Million · 8.1% wtd CAGR ·

    Countries within Asia Pacific - compare and drill down

    Country2025 size (native)
    ChinaUSD 391.3 Million
    JapanUSD 189.4 Million
    IndiaUSD 140.6 Million
    Rest Of Asia PacificUSD 84.1 Million

    Country market size visualization

    China
    USD 391.3 Million
    Japan
    USD 189.4 Million
    India
    USD 140.6 Million
    Rest Of Asia Pacific
    USD 84.1 Million

    Reasons to Buy this Report

    • Regional Market Sizing & Forecasts : Obtain precise market valuations for Asia Pacific biopreservation at USD 986.5M (2024) and USD 1,661.4M (2029), with country-level breakdowns for China, Japan, India, and emerging markets to inform strategic expansion decisions.
    • Competitive Landscape Intelligence : Identify leading biopreservation providers, emerging startups, and technology innovators across Asia Pacific, understanding their market positioning, product portfolios, and growth strategies specific to regional demand drivers.
    • Investment & Partnership Opportunities : Discover high-potential investment targets and partnership opportunities in Asia Pacific's rapidly expanding cell therapy, regenerative medicine, and biobanking sectors with detailed market entry strategies.
    • Regulatory & Compliance Insights : Navigate Asia Pacific's evolving regulatory frameworks across different countries, including biobanking standards, cryopreservation guidelines, and cell therapy approvals to ensure compliant market operations.
    • Growth Driver Analysis : Understand region-specific growth catalysts including government R&D investments, clinical trial expansion, precision medicine adoption, and healthcare infrastructure development driving the 11% CAGR.

    Frequently asked questions

    What is the current size of the Asia Pacific biopreservation market?

    The Asia Pacific biopreservation market was valued at USD 986.5 million in 2024 and is expected to grow to USD 1,661.4 million by 2029.

    What is the growth rate of the Asia Pacific biopreservation market?

    Asia Pacific's biopreservation market is growing at a compound annual growth rate (CAGR) of 11.0% from 2024 to 2029.

    Which countries in Asia Pacific are leading the biopreservation market?

    Established markets like Japan, South Korea, and Australia are leading biopreservation adoption in Asia Pacific, while emerging economies are rapidly building infrastructure.

    What are the primary applications driving Asia Pacific biopreservation demand?

    Key applications in Asia Pacific include stem cell research, organ transplantation, cell therapy, personalized medicine, and biobanking.

    What factors are accelerating biopreservation adoption across Asia Pacific?

    Asia Pacific's growth is driven by rising healthcare expenditure, government life sciences support, aging populations, chronic disease prevalence, and expanding pharmaceutical and biotechnology sectors.

    RESEARCH METHODOLOGY

    The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the Biopreservation market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

    The four steps involved in estimating the market size are:

    Collecting Secondary Data

    The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Biopreservation market. A database of the key industry leaders was also prepared using secondary research.

    Collecting Primary Data

    The primary research data was conducted after acquiring knowledge about the Biopreservation market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as biobanks, gene banks, hospitals, and academic research institute) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and GCC. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

    A breakdown of the primary respondents is provided below:

    Breakdown of Primary Participants:

    Biopreservation Market Size, and Share

    Note 1: *Others include sales managers, marketing managers, and product managers.

    Note 2: Tiers are defined based on a company’s total revenue as of 2023: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    All major product manufacturers offering various Biopreservation were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value Biopreservation market was also split into various segments and subsegments at the region and country level based on:

    • Product mapping of various manufacturers for each type of Biopreservation market at the regional and country-level 
    • Relative adoption pattern of each Biopreservation market among key application segments at the regional and/or country-level 
    • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level. 
    • Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level 

    Global Biopreservation Market Size: Top Down Approach

    Biopreservation Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Global Biopreservation Market Size: Bottom-Up Approach

    Biopreservation Market Size, and Share

    Data Triangulation

    After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Biopreservation industry.

    Market Definition

    Biopreservation is a technique used for the storage of cells and tissues in a hypothermic or chemical environment to preserve biological samples with sustained integrity. The different types of biospecimen stored include human tissue samples, stem cells, and organs, which are majorly used in therapeutic and research applications. These high-yielding cell lines need to be preserved in order to provide optimum yield, viability, and productivity, which can be achieved by cryopreservation and vitrification in a hypothermic storage environment. Biopreservation is a rapidly emerging field of specimen procurement, processing, preservation and banking which requires a close collaboration between clinicians, engineers and scientists coming from academia, small private enterprises or huge industrial companies.

    Key Stakeholders

    • Senior Management
    • Finance/Procurement Department
    • Doctors/HCPs
    • Researchers
    • Lab Managers/Technicians
    • End Users/Operators

    Report Objectives

    • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To define, describe, segment, and forecast the Biopreservation market by product, biospecimen, application, end user, and region.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall Biopreservation market
    • To forecast the size of the Biopreservation market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, Middle East & Africa, and GCC.
    • To profile key players in the Biopreservation market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the Biopreservation market.
    • To benchmark players within the Biopreservation market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

    Available Customizations

    MarketsandMarkets offers the following customizations for this market report:

    • Additional country-level analysis of the Biopreservation market
    • Profiling of additional market players (up to 5)

    Product Analysis

    • Product matrix, which provides a detailed comparison of the product portfolio of each company in the Biopreservation Market

    Get the Full Biopreservation Market Report

    Full forecast, segment splits, and company analysis for all Biopreservation Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status